World's Best Scientists 2026 revealed!
Masataka Kuwana

Masataka Kuwana

D-Index & Metrics

Immunology

D-Index
99
Citations
33445
World Ranking
755
National Ranking
25

Medicine

D-Index
101
Citations
33758
World Ranking
8047
National Ranking
205

Masataka Kuwana publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Masataka Kuwana sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 621 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Masataka Kuwana D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Masataka Kuwana sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Masataka Kuwana is affiliated with Nippon Medical School in Japan and has contributed extensively to research in the field of medicine, with a focus on systemic autoimmune conditions and related pulmonary complications. Their work spans multiple subfields including pathology and forensic medicine, pulmonary and respiratory medicine, epidemiology, rheumatology, and immunology.

Their research topics predominantly cover systemic sclerosis and related diseases, inflammatory myopathies and dermatomyositis, interstitial lung diseases and idiopathic pulmonary fibrosis, eosinophilic disorders and syndromes, dermatologic treatments and research, mast cells and histamine, and rheumatoid arthritis research and therapies.

Recent notable papers include:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial, 2021, The Lancet Respiratory Medicine
  • Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease, 2020, Arthritis & Rheumatology
  • Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype, 2020, CHEST Journal
  • 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases, 2020, Modern Rheumatology

Frequent co-authors in Kuwana's research include Oliver Distler, Lorenzo Cavagna, Latika Gupta, Ashima Makol, and Hector Chinoy, indicating collaborative work across leading experts in related fields.

Their work has appeared in several publication venues, with a significant number of publications in:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Modern Rheumatology
  • Rheumatology International
  • Journal of Scleroderma and Related Disorders

Masataka Kuwana's scholarly output includes over 630 publications centered in medicine, with approximately 130 focusing on pathology and forensic medicine, over 100 in pulmonary and respiratory medicine as well as epidemiology, and substantial work within rheumatology and immunology.

Best Publications

  • Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

    Oliver Distler;Martina Gahlemann;Toby M Maher

  • Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

    Shinji Sato;Michito Hirakata;Masataka Kuwana;Akira Suwa

  • RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

    Shinji Sato;Kana Hoshino;Takashi Satoh;Tomonobu Fujita

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Mortality in systemic sclerosis: An international meta-analysis of individual patient data

    John P.A. Ioannidis;John P.A. Ioannidis;Panayiotis G. Vlachoyiannopoulos;Anna Bettina Haidich;Thomas A. Medsger

  • Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis

    Dinesh Khanna;Daniel E. Furst;Philip J. Clements;Yannick Allanore

  • Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation

    Masataka Kuwana;Yuka Okazaki;Hiroaki Kodama;Keisuke Izumi

  • Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

    Yasuhito Hamaguchi;Manabu Fujimoto;Takashi Matsushita;Kenzo Kaji

  • Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

    Yasuhito Hamaguchi;Masataka Kuwana;Kana Hoshino;Minoru Hasegawa

  • Defective vasculogenesis in systemic sclerosis

    Masataka Kuwana;Yuka Okazaki;Hidekata Yasuoka;Yutaka Kawakami

  • Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

    Takahisa Gono;Shinji Sato;Yasushi Kawaguchi;Masataka Kuwana

  • Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

    Takahisa Gono;Yasushi Kawaguchi;Takashi Satoh;Masataka Kuwana

  • Clinical and Prognostic Associations Based on Serum Antinuclear Antibodies in Japanese Patients with Systemic Sclerosis

    Masataka Kuwana;Junichi Kaburaki;Yutaka Okano;Takeshi Tojo

  • The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.

    Tomohiro Koga;Keita Fujikawa;Yoshiro Horai;Akitomo Okada

  • Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

    Y Ogawa;S Okamoto;T Mori;M Yamada

  • Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities:

    John Varga;Maria Trojanowska;Masataka Kuwana

  • Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.

    M Kuwana;J Kaburaki;Y Ikeda

  • Utility of Anti–Melanoma Differentiation–Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta-Analysis

    Zhiyong Chen;Mengshu Cao;Maria Nieves Plana;Jun Liang

  • Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy

    Yuki Ichimura;Takashi Matsushita;Yasuhito Hamaguchi;Kenzo Kaji

  • Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.

    Siamak Moghadam-Kia;Chester V. Oddis;Shinji Sato;Masataka Kuwana

  • Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation.

    Yoko Ogawa;Masataka Kuwana

Frequent Co-Authors

Yutaka Kawakami
Yutaka Kawakami International University Of Health And Welfare Atami Hospital
Yasuo Ikeda
Yasuo Ikeda Waseda University
Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Oliver Distler
Oliver Distler University of Zurich
Tsuneyo Mimori
Tsuneyo Mimori Kyoto University
Manabu Fujimoto
Manabu Fujimoto Osaka University
Kazuhiko Takehara
Kazuhiko Takehara Kanazawa University
Yasushi Kawaguchi
Yasushi Kawaguchi University of Tokyo
Yannick Allanore
Yannick Allanore Université Paris Cité
Shinichi Sato
Shinichi Sato University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in furthering their expertise in immunology, pursuing related online nursing degrees can be a strategic career move. Many professionals consider specialized programs such as psychiatric-mental health nurse practitioner degrees. When evaluating options, it's important to look into online pmhnp programs with clinical placement to ensure hands-on experience, which is essential for practical learning and job readiness.

Cost can be a significant factor in choosing the right program. Fortunately, there are several affordable options available. Exploring the cheapest pmhnp programs allows students to find quality education without overwhelming financial burden.

Once credentials are earned, understanding potential compensation is key. The dnp salary by state varies widely, influencing where graduates might choose to practice based on salary expectations and cost of living.

For those already working as family nurse practitioners, consider career transitions. Moving from a generalist role to a specialty area is possible and can enhance your scope of practice. Guidance on how to shift roles effectively is detailed in resources about fnp to acute care np pathways.

Best Scientists Citing Masataka Kuwana

Trending Scientists

Recently Published Articles